SOURCE: Industrial Info Resources

Industrial Info Resources

December 03, 2014 06:15 ET

No Wrinkles in Actavis' $66 Billion Deal to Buy Botox Maker Allergan, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Dec 3, 2014) - Reported by Annette Kreuger for Industrial Info Resources (Sugar Land, Texas) -- Pharmaceutical company Allergan (NYSE:AGN) (Irvine, California) has accepted a $66 billion buyout offer from Actavis (NYSE:ACT) (Dublin, Ireland), following months of pursuit by Valeant Pharmaceuticals (NYSE:VRX) (Laval, Quebec). Allergan, known chiefly for wrinkle reducer Botox, had continually spurned Valeant's offers, which had reached a peak of $53 billion last May.

Within this article: Details on the buyout, including a list of plants tracked by Industrial Info.

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, three offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    William Ploch